Free Trial

Enfusion (ENFN) Competitors

$8.49
-0.02 (-0.24%)
(As of 06/14/2024 ET)

ENFN vs. WK, BLKB, ACIW, BOX, FRSH, NCNO, BRZE, INST, AI, and ZETA

Should you be buying Enfusion stock or one of its competitors? The main competitors of Enfusion include Workiva (WK), Blackbaud (BLKB), ACI Worldwide (ACIW), BOX (BOX), Freshworks (FRSH), nCino (NCNO), Braze (BRZE), Instructure (INST), C3.ai (AI), and Zeta Global (ZETA). These companies are all part of the "prepackaged software" industry.

Enfusion vs.

Workiva (NYSE:WK) and Enfusion (NYSE:ENFN) are both computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, media sentiment, risk, valuation, community ranking, dividends and earnings.

Enfusion has lower revenue, but higher earnings than Workiva. Workiva is trading at a lower price-to-earnings ratio than Enfusion, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Workiva$630.04M6.48-$127.53M-$1.72-43.30
Enfusion$174.54M6.23$6.03M$0.03283.09

Enfusion has a net margin of 1.40% compared to Enfusion's net margin of -14.20%. Workiva's return on equity of 6.60% beat Enfusion's return on equity.

Company Net Margins Return on Equity Return on Assets
Workiva-14.20% N/A -7.94%
Enfusion 1.40%6.60%4.86%

In the previous week, Workiva had 6 more articles in the media than Enfusion. MarketBeat recorded 9 mentions for Workiva and 3 mentions for Enfusion. Workiva's average media sentiment score of 1.15 beat Enfusion's score of 0.49 indicating that Enfusion is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Workiva
3 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Enfusion
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Workiva has a beta of 1.07, meaning that its stock price is 7% more volatile than the S&P 500. Comparatively, Enfusion has a beta of 0.96, meaning that its stock price is 4% less volatile than the S&P 500.

Workiva received 386 more outperform votes than Enfusion when rated by MarketBeat users. Likewise, 65.61% of users gave Workiva an outperform vote while only 18.75% of users gave Enfusion an outperform vote.

CompanyUnderperformOutperform
WorkivaOutperform Votes
395
65.61%
Underperform Votes
207
34.39%
EnfusionOutperform Votes
9
18.75%
Underperform Votes
39
81.25%

Workiva currently has a consensus target price of $109.43, suggesting a potential upside of 46.94%. Enfusion has a consensus target price of $9.33, suggesting a potential upside of 9.93%. Given Enfusion's stronger consensus rating and higher possible upside, analysts plainly believe Workiva is more favorable than Enfusion.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Workiva
0 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.86
Enfusion
3 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.67

92.2% of Workiva shares are held by institutional investors. Comparatively, 81.1% of Enfusion shares are held by institutional investors. 3.9% of Workiva shares are held by company insiders. Comparatively, 36.4% of Enfusion shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Workiva beats Enfusion on 10 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ENFN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ENFN vs. The Competition

MetricEnfusionPrepackaged software IndustryComputer SectorNYSE Exchange
Market Cap$1.09B$22.41B$22.97B$17.55B
Dividend YieldN/A2.00%2.70%3.58%
P/E Ratio283.0975.38245.1024.22
Price / Sales6.238.56536.7015.24
Price / Cash59.0467.8231.8219.58
Price / Book13.928.806.624.80
Net Income$6.03M$364.93M$634.07M$978.08M
7 Day Performance-1.51%-0.26%-0.50%0.65%
1 Month Performance-11.88%-5.95%-1.78%-4.13%
1 Year Performance-5.46%1.68%10.69%6.67%

Enfusion Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WK
Workiva
3.4086 of 5 stars
$74.47
+0.4%
$109.43
+46.9%
-27.0%$4.08B$630.04M-43.302,526Analyst Upgrade
News Coverage
BLKB
Blackbaud
4.542 of 5 stars
$76.20
-0.5%
$88.00
+15.5%
+4.8%$3.93B$1.11B185.863,000Short Interest ↓
Positive News
ACIW
ACI Worldwide
3.0934 of 5 stars
$35.79
+0.9%
$40.00
+11.8%
+54.6%$3.77B$1.45B26.713,212Short Interest ↓
Positive News
BOX
BOX
4.2934 of 5 stars
$26.05
+0.7%
$30.33
+16.5%
-13.3%$3.76B$1.04B35.682,530Insider Selling
Short Interest ↑
Positive News
FRSH
Freshworks
3.0763 of 5 stars
$12.31
-0.1%
$22.00
+78.7%
-28.5%$3.68B$623.88M-30.774,900Analyst Upgrade
Short Interest ↑
NCNO
nCino
3.345 of 5 stars
$31.69
+1.0%
$35.64
+12.5%
+24.5%$3.65B$476.54M-102.221,653Insider Selling
Short Interest ↑
News Coverage
BRZE
Braze
3.2808 of 5 stars
$35.86
-0.4%
$60.88
+69.8%
-15.0%$3.62B$471.80M-28.021,548Analyst Forecast
INST
Instructure
1.4489 of 5 stars
$24.66
+1.5%
$29.67
+20.3%
-2.9%$3.60B$530.21M-79.551,496
AI
C3.ai
2.9003 of 5 stars
$29.05
-4.7%
$31.30
+7.7%
-37.3%$3.55B$310.58M-12.41914Short Interest ↓
ZETA
Zeta Global
2.8733 of 5 stars
$16.04
-2.4%
$19.95
+24.4%
+75.6%$3.51B$766.07M-15.131,783Positive News
Gap Up

Related Companies and Tools

This page (NYSE:ENFN) was last updated on 6/16/2024 by MarketBeat.com Staff

From Our Partners